Synonyms: | |
Status: | Phase 1 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 72AUA0603W |
InChI Key | MHXGEROHKGDZGO-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H22F3N5O |
Molecular Weight | 405.42 |
AlogP | 4.05 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 54.69 |
Molecular species | BASE |
Aromatic Rings | 3.0 |
Heavy Atoms | 29.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
CAMK protein kinase group
CAMK protein kinase PIM family
|
200 | 7-48 | - | 12-16 | - | |
Enzyme
Kinase
Protein Kinase
Other protein kinase group
Other protein kinase Haspin family
|
- | 34 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 21-44 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Src family
|
- | 240-2670 | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 511-1000 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Leukemia | 1 | D007938 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1025065-69-3 |
ChEBI | 95061 |
ChEMBL | CHEMBL1952329 |
DrugBank | DB12494 |
EPA CompTox | DTXSID10647329 |
FDA SRS | 72AUA0603W |
Guide to Pharmacology | 8784 |
PubChem | 24795070 |
SureChEMBL | SCHEMBL102498 |
ZINC | ZINC000068205235 |